Can treating critically-ill haematological malignancy patients in a separate intensive care unit decrease intensive care unit mortality?

BACKGROUND/AIM: The aim of the study was to investigate whether treating haematological malignancy (HM) patients in a separate intensive care unit (ICU) would reduce ICU mortality. MATERIALS AND METHODS: HM patients treated by the same ICU team in a general medical ICU (GM-ICU) and a separate haemat...

Descripción completa

Detalles Bibliográficos
Autores principales: AYGENCEL, Gülbin, BOYACI DÜNDAR, Nazlıhan, TÜRKOĞLU, Melda, YEGİN, Zeynep Arzu, ÖZKURT, Zübeyde Nur, YAĞCI, Abdullah Münci
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Scientific and Technological Research Council of Turkey 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8569800/
https://www.ncbi.nlm.nih.gov/pubmed/33992040
http://dx.doi.org/10.3906/sag-2012-107

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8569800/
https://www.ncbi.nlm.nih.gov/pubmed/33992040
http://dx.doi.org/10.3906/sag-2012-107

Ejemplares similares